Eleftheria Mavridou

Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence

Maiken Cavling Arendrup, Eleftheria Mavridou, Klaus Leth Mortensen et al. · PLoS ONE · 2010 · 173 citations · Full text

Antifungal Agent, Azole Resistance, Aspergillus Fumigatus +13

Efficacy of Posaconazole against Three Clinical <i>Aspergillus fumigatus</i> Isolates with Mutations in the <i>cyp51A</i> Gene

Eleftheria Mavridou, Roger J. M. Brüggemann, Willem J. G. Melchers et al. · Antimicrobial Agents and Chemotherapy · 2009 · 112 citations · Full text

Impact of <i>cyp51A</i> Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis

Eleftheria Mavridou, Roger J. M. Brüggemann, Willem J. G. Melchers et al. · Antimicrobial Agents and Chemotherapy · 2010 · 84 citations · Full text

Pharmacodynamics of Imipenem in Combination with β-Lactamase Inhibitor MK7655 in a Murine Thigh Model

Eleftheria Mavridou, Ria J. B. Melchers, Anita C. H. A. M. van Mil et al. · Antimicrobial Agents and Chemotherapy · 2014 · 46 citations · Full text

Klebsiella Pneumoniae, Pharmacotherapy, Antimicrobial Chemotherapy +23

Epidemiological Cutoff Values for Azoles and Aspergillus fumigatus Based on a Novel Mathematical Approach Incorporating <i>cyp51A</i> Sequence Analysis

Joseph Meletiadis, Eleftheria Mavridou, Willem J. G. Melchers et al. · Antimicrobial Agents and Chemotherapy · 2012 · 40 citations · Full text

Fungal Diversity, Antifungal Agent, Promoter Region +11